NASDAQ:ABCL | Cash Flow Statement | AbCellera Biologics Inc.

Complete source-backed cash-flow history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$55.43M$6.99M
2026-03-31-$43.17M$6.84M-$33.52M$3.83M-$25.08M$7.19M
2025-12-31-$8.95M-$34.74M$9.84M$75.14M$4.12M
2025-09-30-$57.12M
2025-06-30-$34.73M$5.47M
2025-03-31-$45.62M$5.33M-$11.55M$10.64M$7.94M$5.97M
2024-12-31-$34.21M-$8M$15.63M$35.7M$4.14M
2024-09-30-$51.11M
2024-06-30-$36.93M
2024-03-31-$40.61M-$41.71M$24.14M$29.91M$2.83M
2023-12-31-$47.15M-$19.61M$14.43M-$24.32M$3.77M
2023-09-30-$28.61M
2023-06-30-$30.53M
2023-03-31-$40.11M-$44.06M$14.98M-$149.61M-$458,000.00
2022-12-31-$29.89M$30.91M$12.33M-$17.06M$349,000.00
2022-09-30$26.62M
2022-06-30-$6.79M
2022-03-31$168.57M$100.22M$14.5M-$26.37M-$3.13M
2021-12-31$59.95M-$16.71M$9.43M-$1.15M$1.83M
2021-09-30-$21.38M
2021-06-30-$2.32M
2021-03-31$117.22M$109.55M$3.64M-$15.84M-$1.54M
2020-12-31$117M$1.28M$1.5M-$108.18M$609.94M
2020-09-30-$2.69M
2020-06-30$6.7M
2020-03-31-$2.09M-$764,000.00$583,000.00-$5.58M$87.74M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$146.41M-$131.3M$42.77M$87.75M$14.08M
2024-12-31-$162.86M-$108.56M$78.4M$121.41M$12.77M
2023-12-31-$146.4M-$43.88M$76.95M-$221.11M$10.36M
2022-12-31$158.52M$277.36M$70.66M-$352.63M-$1.63M
2021-12-31$153.46M$244.58M$58.45M-$332.25M-$3.89M
2020-12-31$118.92M$22.69M$9.67M-$119.78M$683.65M
2019-12-31-$2.21M$2.69M$4M-$5.78M$195,000.00